Latest California Healthline Stories
Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
Jennifer Haberkorn of the Los Angeles Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to answer listener questions about the fate of the Affordable Care Act, “Medicare-for-all“ and how to talk about health care costs. Also, for extra credit, the panelists offer their favorite “extra credit” stories of the week.
Watch: Sanders Re-Ups ‘Medicare-For-All,’ Gets More Mileage On Campaign Trail
The plan by Sanders has drawn a lot of attention on the campaign trail and Capitol Hill.
Podcast: KHN’s ‘What The Health?’ Still More ‘Medicare-For-All’
Sarah Kliff of Vox.com, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss the latest version of a “Medicare-for-all” bill by Sen. Bernie Sanders (I-Vt.), a presidential hopeful, and Democratic and Republican reactions to it. They also discuss the latest on congressional efforts to rein in drug prices and another state effort to expand Medicaid — but not exactly in the way voters wanted. Also, Rovner interviews Ceci Connolly of the Alliance of Community Health Plans.
Making Smarter Decisions About Where To Recover After Hospitalization
Older adults — and their families — often find it challenging and stressful to find the best facility. And they often end up in the wrong spot, new research shows.
As Sanders Officially Revives Medicare-For-All, Plan B For Democrats Gains Traction
“Medicare for America” seeks to avoid some of the predictable obstacles of a full-blown expansion of Medicare. Can it survive the politics of health reform?
Consumers Rejected Drug Plan That Mirrors Trump Administration Proposal
What to know about PBMs and rebates ahead of the Senate drug price hearing on — you guessed it — PBMs.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Doughnut Hole Is Gone, But Medicare’s Uncapped Drug Costs Still Bite Into Budgets
Beneficiaries pay 25 percent of the price of their brand-name drugs until they reach $5,100 in out-of-pocket costs. After that, their obligation drops to 5 percent. But it never disappears.
Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
Some plans are experimenting with the idea of closely tying hospital reimbursement rates to what Medicare pays. The approach could be a game changer in their effort to control health costs.
Confusión costosa: visita de bienestar de Medicare no es lo mismo que el chequeo anual
Es esencial que los adultos mayores sepan la diferencia entre ambas visitas al consultorio y lo que está cubierto, para no recibir cuentas médicas sorpresa.